The change of serum C-reactive protein levels during molecular-targeted treatments could predict the response to anti-PD-1 treatment in metastatic renal cell carcinoma patients
The change of serum C-reactive protein levels during molecular-targeted treatments could predict the response to anti-PD-1 treatment in metastatic renal cell carcinoma patients
复制标题
分子靶向治疗期间血清C反应蛋白水平的变化可以预测转移性肾细胞癌患者对抗PD-1治疗的反应
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Oya M
中科院分区：
文献类型：
--
作者：
Takamatsu K;Mizuno R;Hayakawa N;Tanaka N;Kosaka T;Kikuchi E;Oya M
